Novel Biomarkers in the Continuum of Breast Cancer

  • Vered Stearns

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 882)

Also part of the Breast Cancer Research Foundation book sub series (BCRF, volume 882)

Table of contents

  1. Front Matter
    Pages i-xix
  2. Michael F. Walsh, Katherine L. Nathanson, Fergus J. Couch, Kenneth Offit
    Pages 1-32
  3. Mary Beth Terry, Jasmine A. McDonald, Hui Chen Wu, Sybil Eng, Regina M. Santella
    Pages 33-68
  4. Carol J. Fabian, Bruce F. Kimler
    Pages 69-94
  5. Omar Mahmoud, Bruce G. Haffty
    Pages 95-124
  6. Vinay Varadan, Maria Sandoval, Lyndsay N. Harris
    Pages 155-167
  7. Francisco Beca, Kornelia Polyak
    Pages 169-189
  8. Daniel L. Hertz, James M. Rae
    Pages 191-215
  9. Christopher D. Hart, Leonardo Tenori, Claudio Luchinat, Angelo Di Leo
    Pages 217-234
  10. Costanza Paoletti, Daniel F. Hayes
    Pages 235-258
  11. Heather A. Parsons, Julia A. Beaver, Ben H. Park
    Pages 259-276
  12. Back Matter
    Pages 277-279

About this book


This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to today’s standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research.

Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment for individual patients.


Anti HER2 agents Epigenetics breast cancer research foundation breast cancer therapeutics genetic biomarkers

Editors and affiliations

  • Vered Stearns
    • 1
  1. 1.Johns Hopkins UniversitySidney Kimmel Comprehensive Cancer Ctr.BALTIMOREUSA

Bibliographic information